BlackRock Health Sciences Trust
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $39.62
- Today's High:
- $39.83
- Open Price:
- $39.83
- 52W Low:
- $36.7454
- 52W High:
- $44.1397
- Prev. Close:
- $39.84
- Volume:
- 33950
Company Statistics
- Market Cap.:
- $557.19 million
- Book Value:
- 43.303
- Revenue TTM:
- $7.73 million
- Operating Margin TTM:
- 19.91%
- Gross Profit TTM:
- $7.73 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0.15%
- Return on Equity TTM:
- -4.32%
Company Profile
BlackRock Health Sciences Trust had its IPO on 2005-03-29 under the ticker symbol BME.
The company operates in the Financial Services sector and Asset Management industry. BlackRock Health Sciences Trust has a staff strength of 0 employees.
Stock update
Shares of BlackRock Health Sciences Trust opened at $39.83 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $39.62 - $39.83, and closed at $39.62.
This is a -0.55% slip from the previous day's closing price.
A total volume of 33,950 shares were traded at the close of the day’s session.
In the last one week, shares of BlackRock Health Sciences Trust have slipped by -1.12%.
BlackRock Health Sciences Trust's Key Ratios
BlackRock Health Sciences Trust has a market cap of $557.19 million, indicating a price to book ratio of 1.2301 and a price to sales ratio of 82.625.
In the last 12-months BlackRock Health Sciences Trust’s revenue was $7.73 million with a gross profit of $7.73 million and an EBITDA of $0. The EBITDA ratio measures BlackRock Health Sciences Trust's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, BlackRock Health Sciences Trust’s operating margin was 19.91% while its return on assets stood at 0.15% with a return of equity of -4.32%.
In Q1.3333333333333, BlackRock Health Sciences Trust’s quarterly earnings growth was a positive 76.2% while revenue growth was a positive 26.4%.
BlackRock Health Sciences Trust’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-2.1 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BlackRock Health Sciences Trust’s profitability.
BlackRock Health Sciences Trust stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 82.625.
BlackRock Health Sciences Trust stock pays annual dividends of $2.556 per share, indicating a yield of 6.34% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $606.13 million
- Total Liabilities
- $233198.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
BlackRock Health Sciences Trust ended 2024 with $606.13 million in total assets and $0 in total liabilities. Its intangible assets were valued at $606.13 million while shareholder equity stood at $600.20 million.
BlackRock Health Sciences Trust ended 2024 with $0 in deferred long-term liabilities, $233198.00 in other current liabilities, 424300067.00 in common stock, $175.90 million in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
BlackRock Health Sciences Trust’s total current assets stands at $2.37 million while long-term investments were $603.68 million and short-term investments were $0. Its net receivables were $2.37 million compared to accounts payable of $233198.00 and inventory worth $0.
In 2024, BlackRock Health Sciences Trust's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, BlackRock Health Sciences Trust paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $39.62
- 52-Week High
- $44.1397
- 52-Week Low
- $36.7454
- Analyst Target Price
- $
BlackRock Health Sciences Trust stock is currently trading at $39.62 per share. It touched a 52-week high of $44.1397 and a 52-week low of $44.1397. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $39.82 and 200-day moving average was $40.53 The short ratio stood at 0.5 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 1820.2% are held by institutions.
Frequently Asked Questions About BlackRock Health Sciences Trust
Similar Industry Stocks (Asset Management)
Most Active
Top Gainers
Top Losers
About
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.